Navigation Links
Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2008 Third Quarter Earnings Conference Call on Thursday, May 15, 2008 at 9:00 a.m. EDT
Date:5/14/2008

et income of $3.95 million in FY2007 ending June 30, 2007.

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.

For more information, please contact:

For the Company:

Allen Tang, Ph.D., MBA, Assistant to the CEO

Tel: +86-158-2122-5642

Email: Allen.y.tang@gmail.com

Investors:

HC International, Inc.

Alan Sheinwald

Tel: +1-914-669-0222

Email: Alan.Sheinwald@hcinternational.net


'/>"/>
SOURCE Tianyin Pharmaceutical, Co., Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time
2. Viscorp, Inc. Announces Name Change to Tianyin Pharmaceutical Co Inc. and Begins Trading Under the Ticker OTC BB: TYNP
3. Simcere Pharmaceutical Group Announces SFDA Approval of First-to-Market Generic Biapenem Injection Anxin
4. MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results
5. Ferring Pharmaceuticals EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic
6. Sunesis Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
7. MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results
8. Benda Pharmaceutical Appoints Jun Tang to Board of Directors
9. Alseres Pharmaceuticals to Host 2008 First Quarter Conference Call
10. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Third Quarter Results of Fiscal Year 2008
11. Par Pharmaceutical Reports First Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... In the April issue of Experimental Biology ... by Drs. Rex Gaskins and Paul Kenis in ... campus of the University of Illinois Urbana-Champaign describe ... reduction-oxidation reactions underlie a variety of cell functions ... to these crucial roles in regulating normal cellular ...
(Date:4/17/2014)... Hospital Pediatrician-in-Chief Jon McCullers, MD, was recently invited ... of Nature Reviews Microbiology , one of ... a world-renowned infectious disease specialist, and chair of ... Tennessee Health Science Center, analyzed the epidemiology and ... 1968 pandemics, as well as more recent 2009 ...
(Date:4/17/2014)... that as many as 10 million older Americans suffer ... and isolation. , However, new research a project ... Americans for six years found that Internet use ... by more than 30 percent. , "That,s a very ... professor of telecommunication, information studies and media who led ...
(Date:4/17/2014)... BostonResearchers from Boston University School of Medicine (BUSM) ... alcohol consumption in an experimental model. The findings, ... and Alcohol Abuse , may lead to more ... alcohol is one of the leading causes of ... significant negative economic impact by limiting the productivity ...
(Date:4/17/2014)... A. Arias, M.D., Ph.D., at The University of Texas ... new superbug that caused a bloodstream infection in a ... issue of The New England Journal of Medicine ... class of highly-resistant bacteria known as methicillin-resistant Staphylococcus ... of hospital and community-associated infections. The superbug has also ...
Breaking Medicine News(10 mins):Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Internet use can help ward off depression among elderly 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:New MRSA superbug emerges in Brazil 2
... ... care than other nations. Low back pain is the number two most common reason Americans ... spinal issues will now be able to see, touch and thereby better understand common spinal ... Issaquah, WA ...
... new study finds that Hispanics live in areas ... for colorectal cancer screening. Published early online in ... American Cancer Society, the study indicates that differences ... explain why Hispanics are less likely to undergo ...
... Atomic Force Microscope depicts on its screen the few ... flexible sticks, crisscrossing the surface on which they are ... in fact that they can self assemble into complex ... and University of Fribourg have teamed up to take ...
... SCD Probiotics ... to bring aid to the people of Chile. Donations are currently being raised to ... Valparaiso where it will be used and distributed, primarily through the Chilean military., , ... (PRWEB) April 11, 2010 -- In ...
... boosts performance, study finds , FRIDAY, April 9 (HealthDay ... medication react more like other children when faced with ... researchers have found. , The findings, published in the ... that the medication does what it,s supposed to do: ...
... ... in the state, Dr. Jeffrey Raval has pioneered a new process to make the injections ... fillers, a practice that the FDA approved in 2009. , ... Denver, Colo. (PRWEB) April 10, 2010 -- As an injector ...
Cached Medicine News:Health News:Latest Resource From Dynamic Disc Designs Helps Physicians Educate Patients 2Health News:Latest Resource From Dynamic Disc Designs Helps Physicians Educate Patients 3Health News:Hispanics live in areas with limited capacity for colorectal cancer screening 2Health News:The assembly of protein strands into fibrils 2Health News:Beneficial Microorganisms Rescue Chilean Earthquake Victims 2Health News:Beneficial Microorganisms Rescue Chilean Earthquake Victims 3Health News:Dr. Jeffrey Raval Pioneers New Method for Filler Facelifts 2Health News:Dr. Jeffrey Raval Pioneers New Method for Filler Facelifts 3
(Date:1/14/2014)... 2014 /PRNewswire-iReach/ -- Acumed,s new SLIC Screw System - ... instrumentation to place and insert the screw accurately - ... (e.g. ligament) repair or reconstruction as it holds the ... (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) The SLIC ...
(Date:1/14/2014)... CLEVELAND , Jan. 14, 2014 NineSigma ... will hold its Innovation Leadership Summit , May ... in Cleveland Ohio . ... innovators and organizations committed to breakthrough achievements through open ...
(Date:1/14/2014)... 14, 2014   Evidera , a leading provider of ... Center for Drug Evaluation and Research (CDER), U.S. Food ... guidance document for a patient-reported outcome (PRO) measure in ... Disease Tool [EXACT] for Measurement of Symptoms of Acute ...
Breaking Medicine Technology:Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 3Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 4
... 14, 2007-Acceleron Pharma, Inc., a,biopharmaceutical company developing ... cancer-related diseases, today,announced results of a preclinical ... the compound to increase muscle mass,and strength ... of muscular,dystrophy. ACE-031 inhibits negative regulators of ...
... Biotechnology reports positive results from placebo,controlled phase ... dust,mite allergy , ,SCHLIEREN (Zurich), Switzerland, May ... today positive results from a multi-centre,and placebo-controlled ... an immunotherapeutic product candidate for the,treatment of ...
Cached Medicine Technology:Accelreon Pharma's ACE-031Shown to Increase Muscle Mass in,Preclinical Studies 2Accelreon Pharma's ACE-031Shown to Increase Muscle Mass in,Preclinical Studies 3Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 2Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 3Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 4Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 5Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 6Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 7
1 mm wide by 28 mm long sterling silver blade. Flat serrated handle with polished finish....
Lasik spatula useful for protecting a previous flap for retreatment to lift and smooth the corneal flap....
Triangular 0.5 mm angled tip with 4 mm flat surface. Round knurled handle with dull finish. Tip angle: 150o....
Angled blade and flat serrated handle with polished finish. Blade: 1 mm x 10 mm....
Medicine Products: